Thought Leadership
Read our insights and commentary about pharmaceutical industry news and healthcare innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.
Showing 5 of 9 posts
September 27, 2021 | Blogs
AI-Based Software Paige Prostate is Granted FDA Approval Through the De Novo Regulatory Pathway
CBPartners' Digital Therapeutics & Health Technology Expertise Team summarizes the approval of the first AI-based software designed to identify areas of concern on a prostate biopsy image.
August 30, 2021 | Blogs
Verily to Acquire SignalPath, Expanding the Company’s Clinical Research Capabilities
Verily recently announced its first major acquisition, a software platform known as SignalPath. The acquisition would fold SignalPath into Baseline, Verily’s clinical research platform.
April 14, 2021 | Blogs
Interview Series with Leaders of DTx: Challenges & Opportunities for Commercialization
In this three-part series, CBPartners’ Digital Therapeutics & Health Technology Expertise Team interviews some of the leaders of the digital therapeutics (DTx) space to collect their thoughts on the current challenges and opportunities for DTx commercialization.
February 19, 2021 | Infographics
KAISER Integrates DTx Into the Behavioral Health Treatment Paradigm at No Extra Cost After a Clinician Referral
KAISER’s recent systemic integration of digital health therapeutics (DTx) into the treatment paradigm for behavioral health concerns is a step towards modernizing healthcare and represents a very structured approach to real-world data generation.
November 3, 2020 | Infographics
ICER Released First Cost-Effectiveness Assessment for a Digital Therapeutic (DTx)
Digital Therapies for Opioid Use Disorder (OUD) have been assessed by ICER to determine whether they are effective, both in terms of cost, and improvement in retention in treatment.